Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Sarcoma, Ewing, Osteosarcoma

Lung Neoplasms

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Extensive Stage Lung Small Cell Cancer

Ovarian Neoplasms

SCLC, Extensive Stage

Recurrence, Small Cell Lung Carcinoma

Extensive Small Cell Lung Cancer

Small Cell Lung Carcinoma

Carcinoma, Carcinoma, Pancreatic Ductal

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Unresectable Locally Advanced or Metastatic Solid Tumors

Recurrence, Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Merkel Cell

Osteosarcoma

Lung Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

SYS6090 Combination Therapy in Advanced Lung Cancer

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

ALL Backbone in AYAs

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Adjuvant

QL1706

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Using Tumor Models to Determine Treatments

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer

NeoSCLC-001

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

PANDORA

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases